Xbrane Biopharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	79.44	-266.22	-388.17	-172.51	-188.38	-226.03	Upgrade
Depreciation & Amortization	23.22	24.21	21.43	16.58	12.22	5.77	Upgrade
Other Amortization	-	-	-	-	-	0.79	Upgrade
Stock-Based Compensation	-	-	-	-	-	1.29	Upgrade
Other Operating Activities	-246.18	67.22	145.36	-7.25	-5.04	-1.61	Upgrade
Change in Accounts Receivable	89.3	-4.56	-85.13	1.7	-61.09	-51.33	Upgrade
Change in Inventory	2.58	-166	-56.6	-50.26	-	-	Upgrade
Change in Accounts Payable	-246.07	212.82	22.57	-	-	-	Upgrade
Change in Other Net Operating Assets	-	-	-	17.83	22.67	32.7	Upgrade
Operating Cash Flow	-54.69	-133.73	-406.68	-193.92	-219.61	-238.41	Upgrade
Capital Expenditures	-62.4	-0.5	-6.79	-11.62	-27.68	-3.86	Upgrade
Sale (Purchase) of Intangibles	-51.75	-51.75	-9.98	-48.51	-49.67	-	Upgrade
Other Investing Activities	97.5	-	-	-	-	-	Upgrade
Investing Cash Flow	-16.65	-52.25	-16.77	-60.13	-77.35	-3.86	Upgrade
Long-Term Debt Issued	-	70	225	-	-	-	Upgrade
Long-Term Debt Repaid	-	-126.14	-34.74	-8.34	-7.27	-3.14	Upgrade
Total Debt Repaid	-34.22	-126.14	-34.74	-8.34	-7.27	-3.14	Upgrade
Net Debt Issued (Repaid)	5.78	-56.14	190.26	-8.34	-7.27	-3.14	Upgrade
Issuance of Common Stock	-	337.24	120.02	170.55	380.87	346.45	Upgrade
Other Financing Activities	-0.04	-37.48	-11.58	-13.35	-24.23	-20.58	Upgrade
Financing Cash Flow	5.74	243.62	298.7	148.86	349.37	322.72	Upgrade
Foreign Exchange Rate Adjustments	-1.85	0.84	-4.49	4.05	1.39	-1.52	Upgrade
Miscellaneous Cash Flow Adjustments	0.48	0.44	0.64	-0.05	-1.76	-	Upgrade
Net Cash Flow	-66.97	58.93	-128.59	-101.19	52.04	78.94	Upgrade
Free Cash Flow	-117.09	-134.23	-413.47	-205.53	-247.29	-242.26	Upgrade
Free Cash Flow Margin	-44.06%	-67.55%	-173.20%	-356.72%	-2309.16%	-	Upgrade
Free Cash Flow Per Share	-0.08	-0.11	-14.40	-8.04	-10.48	-13.38	Upgrade
Cash Interest Paid	17.65	17.65	7.58	2.59	2.64	0.69	Upgrade
Levered Free Cash Flow	-118.76	-67	-244	-169.78	-279.72	-153.39	Upgrade
Unlevered Free Cash Flow	-99.58	-45.98	-232.43	-168.17	-278.07	-152.96	Upgrade
Change in Working Capital	-154.19	42.27	-119.16	-30.73	-38.42	-18.63	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.